Literature DB >> 19929700

The changing pattern of adherence to antiretroviral therapy assessed at two time points, 12 months apart, in a cohort of HIV-infected children.

Antonietta Giannattasio1, Fabio Albano, Vania Giacomet, Alfredo Guarino.   

Abstract

OBJECTIVE: In a previous multicentre study including 129 HIV-infected children, non-adherence to antiretroviral therapy was detected in 16% of patients and was mainly related to psychosocial rather than clinical or demographic features. The aim of this study was to explore the evolving pattern of adherence and its determinants in the same population of children.
METHODS: An observational, cross-sectional multicentre study was done through a structured interview to the caregivers of HIV-infected children. Adherence was quantitatively evaluated through a 4-day recall adherence instrument.
RESULTS: One hundred and twelve children were included. Nineteen (17%) omitted more than 5% of doses in the preceding 4 days and were considered non-adherent. Of these, 10 had been found non-adherent and nine adherent in the previous study. In parallel, nine of the originally non-adherent children had become adherent. Adherence rates were higher in children receiving therapy from foster parents than in children receiving therapy from biological parents. Dose number significantly correlated with adherence.
CONCLUSIONS: Adherence to antiretroviral therapy is a dynamic phenomenon that changes with time. The evolving pattern shows a fairly constant distribution of adherence because a similar number of patients gain and lose adherence. Psychosocial rather than clinical features are major determinants of adherence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19929700     DOI: 10.1517/14656560903376178

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  9 in total

1.  Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

Authors:  Natella Y Rakhmanina; John N van den Anker; Steven J Soldin; Ron H van Schaik; Nick Mordwinkin; Michael N Neely
Journal:  Ther Drug Monit       Date:  2010-06       Impact factor: 3.681

2.  Pharmacokinetics of lopinavir determined with an ELISA test in youths with perinatally acquired HIV.

Authors:  Roberta Prinapori; Raffaella Rosso; Antonio Di Biagio; Franca Miletich; Elisa Furfaro; Lucia Taramasso; Francesca Ginocchio; Vania Giacomet; Loredana Nulvesu; Maria Pia Sormani; Irene Schiavetti; Alessio Signori; Laura De Hoffer; Claudio Viscoli
Journal:  Indian J Pediatr       Date:  2013-09-07       Impact factor: 1.967

3.  Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy.

Authors:  Ellen G Chadwick; Ram Yogev; Carmelita G Alvero; Michael D Hughes; Rohan Hazra; Jorge A Pinto; Brian L Robbins; Barbara E Heckman; Paul E Palumbo; Edmund V Capparelli
Journal:  AIDS       Date:  2011-03-13       Impact factor: 4.177

4.  Family group psychotherapy to support the disclosure of HIV status to children and adolescents.

Authors:  Emanuele Nicastro; Grazia Isabella Continisio; Cinzia Storace; Eugenia Bruzzese; Carmela Mango; Ilaria Liguoro; Alfredo Guarino; Annunziata Officioso
Journal:  AIDS Patient Care STDS       Date:  2013-05-21       Impact factor: 5.078

5.  Early antiretroviral therapy-treated perinatally HIV-infected seronegative children demonstrate distinct long-term persistence of HIV-specific T-cell and B-cell memory.

Authors:  Nicola Cotugno; Elena Morrocchi; Stefano Rinaldi; Salvatore Rocca; Ilaria Pepponi; Silvia di Cesare; Stefania Bernardi; Paola Zangari; Suresh Pallikkuth; Lesley de Armas; Ofer Levy; Paolo Rossi; Savita Pahwa; Paolo Palma
Journal:  AIDS       Date:  2020-04-01       Impact factor: 4.632

6.  The Transition of Care From Pediatric to Adult Health-Care Services of Vertically HIV-Infected Adolescents: A Pilot Study.

Authors:  Grazia Isabella Continisio; Andrea Lo Vecchio; Francesca Wanda Basile; Carla Russo; Maria Rosaria Cotugno; Giulia Palmiero; Cinzia Storace; Carmela Mango; Alfredo Guarino; Eugenia Bruzzese
Journal:  Front Pediatr       Date:  2020-07-02       Impact factor: 3.418

7.  Viral suppression among children and their caregivers living with HIV in western Kenya.

Authors:  John M Humphrey; Becky L Genberg; Alfred Keter; Beverly Musick; Edith Apondi; Adrian Gardner; Joseph W Hogan; Kara Wools-Kaloustian
Journal:  J Int AIDS Soc       Date:  2019-04       Impact factor: 6.707

8.  Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors.

Authors:  Dwight E Yin; Christina Ludema; Stephen R Cole; Carol E Golin; William C Miller; Meredith G Warshaw; Ross E McKinney
Journal:  PLoS One       Date:  2020-11-23       Impact factor: 3.240

9.  Personal barriers to antiretroviral therapy adherence: case studies from a rural Uganda prospective clinical cohort.

Authors:  B N Mayanja; E Kabunga; B Masiira; R Lubega; P Kaleebu; J Seeley
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.